Page last updated: 2024-08-25

fangchinoline and Benign Neoplasms

fangchinoline has been researched along with Benign Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Check Hayden, E1
Ahn, KS; Arfuso, F; Fan, L; Mérarchi, M; Mishra, S; Sethi, G1

Reviews

1 review(s) available for fangchinoline and Benign Neoplasms

ArticleYear
Molecular Targets Modulated by Fangchinoline in Tumor Cells and Preclinical Models.
    Molecules (Basel, Switzerland), 2018, Oct-05, Volume: 23, Issue:10

    Topics: Alkaloids; Apoptosis; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Humans; Molecular Targeted Therapy; Neoplasms; Stephania tetrandra

2018

Other Studies

1 other study(ies) available for fangchinoline and Benign Neoplasms

ArticleYear
The rise and fall and rise again of 23andMe.
    Nature, 2017, 10-11, Volume: 550, Issue:7675

    Topics: Antibodies, Monoclonal; Benzylisoquinolines; Biosensing Techniques; Bloom Syndrome; Cardiovascular Diseases; Disclosure; Drug Discovery; False Positive Reactions; Gaucher Disease; Genes, BRCA1; Genes, BRCA2; Genetic Predisposition to Disease; Genetic Testing; Genome-Wide Association Study; Heredity; Humans; Iceland; Immune System Diseases; Information Dissemination; Neoplasms; Parkinson Disease; Pharmacogenetics; Predictive Value of Tests; Reproducibility of Results; Self Report; Skin Diseases; Translational Research, Biomedical; United States; United States Food and Drug Administration

2017